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Background: We report a multiinstitutional study on intermediate-term outcome of intra-
vascular stenting for treatment of coarctation of the aorta using integrated arch imaging
(IAI) techniques. Methods and Results: Medical records of 578 patients from 17 institu-
tions were reviewed. A total of 588 procedures were performed between May 1989 and
Aug 2005. About 27% (160/588) procedures were followed up by further IAI of their aorta
(MRI/CT/repeat cardiac catheterization) after initial stent procedures. Abnormal imaging
studies included: the presence of dissection or aneurysm formation, stent fracture, or
the presence of reobstruction within the stent (instent restenosis or significant intimal
build-up within the stent). Forty-one abnormal imaging studies were reported in the inter-
mediate follow-up at median 12 months (0.5–92 months). Smaller postintervention of the
aorta (CoA) diameter and an increased persistent systolic pressure gradient were associ-
ated with encountering abnormal follow-up imaging studies. Aortic wall abnormalities
included dissections (n = 5) and aneurysm (n = 13). The risk of encountering aortic wall
abnormalities increased with larger percent increase in CoA diameter poststent implant,
increasing balloon/coarc ratio, and performing prestent angioplasty. Stent restenosis
was observed in 5/6 parts encountering stent fracture and neointimal buildup (n = 16).
Small CoA diameter poststent implant and increased poststent residual pressure gradi-
ent increased the likelihood of encountering instent restenosis at intermediate follow-up.
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Conclusions: Abnormalities were observed at intermediate follow-up following IS place-
ment for treatment of native and recurrent coarctation of the aorta. Not exceeding a bal-
loon:coarctation ratio of 3.5 and avoidance of prestent angioplasty decreased the likeli-
hood of encountering an abnormal follow-up imaging study in patients undergoing intra-
vascular stent placement for the treatment of coarctation of the aorta. We recommend
IAI for all patients undergoing IS placement for treatment of CoA. ' 2007 Wiley-Liss, Inc.
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BACKGROUND
Over the past two decades, endovascular stent im-
plantation has become an accepted modality for treat-
ment of native and recurrent coarctation of the aorta
(CoA) in older children and adults [1–17]. However,
follow-up has primarily been limited to clinical blood
pressure measurements, echocardiographic evaluation,
and chest X-ray [3,10,12]. Sensitivity of either chest
X-ray or echocardiography in detecting aneurysms or
restenosis following stent placement has been ques-
tioned [11]. Integrated arch imaging (IAI) following
stent placement by cardiac catheterization, CT scan, or
magnetic resonance imaging (MRI) would offer optimal
assessment of the aortic arch, but has been sparsely
reported. We report a multiinstitutional study on the
intermediate-term outcome of intravascular stenting for
treatment of CoA using IAI techniques.
METHODS
A retrospective review of the medical record charts
of all patients undergoing intravascular stent placement
for the treatment of native and recurrent CoA was per-
formed. At each institution, internal review board
approval was obtained, with Health Information and
Privacy Assurance Act guidelines being met. A total
of 17 institutions contributed to this study. Patients
undergoing further IAI (either MRI/CT/repeat cardiac
catheterization) following initial stent procedure made
up our cohort group for which further analysis was
done. Imaging was evaluated by the investigator at
each institution. Strict definitions were followed in
classification of various lesions. Data forms were then
sent to the coordinating center for further analysis. Fif-
teen patients undergoing IAI have been included in pre-
viously published reports [3,12–15]. Data of 16 proce-
dures undergoing staged approach to stent dilation were
noted, though were excluded from further analysis. Com-
parisons were made between those patients who were
noted to have normal imaging studies (group A) and
those having abnormal imaging studies (group B) at fol-
low-up. Patients with abnormal follow-up imaging stud-
ies were further subdivided into: (1) vessel injury,
including dissection and/or aneurysm, and (2) in-stent re-
stenosis, including intimal hyperplasia, stent fracture,
and/or stent recoil. Follow-up imaging findings were cor-
related with patient and procedural characteristics to
determine if associations existed between the groups.
Demographic Information
Patient demographic information obtained at time of
initial stent implantation included: patient age, weight,
CoA type (native vs. recurrent), associated cardiac
lesions, minimal CoA diameter, CoA length, CoA loca-
tion (transverse arch, isthmus, or other), and prestent
pressure gradient. Procedural information obtained at
time of stent implantation included: performance of
prestent angioplasty, balloon:CoA ratio, type of stent,
the presence of complications (which were further bro-
ken down to the presence of aortic wall injury vs. the
occurrence of a technical complication), minimal CoA
diameter poststent implant, percent increase in CoA
diameter poststent implant, poststent residual pressure
gradient, and subclavian/carotid vessel overlap by
stent. If a repeat catheterization was performed, mea-
surements were obtained prior to reintervention.
Definitions
Aneurysm was defined as a >10% expansion of the
aorta outside the stent or normal aorta that was not
present prior to the intervention. Dissection was termed
as an extravasation of contrast outside the vessel wall.
Intimal flap was noted when a thin filling defect was
observed within the vessel lumen. In-stent restenosis
was noted when greater than 10% of the stent lumen
was obstructed either due to intimal proliferation
within the stent, stent fracture, or stent recoil.
Statistical Analysis
Abnormal follow-up imaging included the presence
of dissection, aneurysm, or in-stent restenosis. After
excluding the results from 16 procedures which under-
went planned stage procedures, outcomes were divided
into group A (normal follow-up imaging), and group B
(abnormal follow-up imaging). We further subdivided
group B into: aortic wall injury group and in-stent
restenosis group. The mean and standard error were
calculated for continuous parameters, such as age,
weight, pre- and postintervention data. The frequency
and percentage were calculated for parameters such as
characteristics and location of coarctation, prestent
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angiography, presence of acute complication, and types
of complications. Group comparisons were evaluated
using T-test, v2, and Fish exact test. Statistical signifi-
cance was set at P  0.05. All analyses were per-
formed with SAS version 8.2 statistical software (SAS
Institute, Cary, NC) using default settings.
RESULTS
The medical charts and records from 17 medical
institutions were included in the study. A total of 588
cardiac catheterization procedures were performed in
578 patients, with 650 stents being placed. The 160
patients available for follow-up have undergone IAI.
About 50 patients had CT imaging, 20 patients had
MRI, and rest of 90 patients had repeat cardiac cathe-
terization. Sixteen patients (10%) underwent a planned
stage procedure. No dissection or aneurysm formation
was observed in this subgroup. Different criteria for
final stent expansion were used for these parts in com-
parison with parts undergoing one stage treatment of
their coarctation. Because of separate criteria being
used at time of the initial procedure, we excluded
these patients from further analysis. Though, if after
having undergone the second stage, they underwent
follow-up integrated imaging of their aortic arch, they
were included in the study. Therefore, only patients
undergoing final expansion of their stent underwent
further analyses (n ¼ 144).
Median follow-up interval in all patients was 12 months
(range 0.5–92 months). Follow-up IAI studies were done
as protocol at three institutions (n ¼ 63). The majority of
imaging studies were performed either due to concerns of
reobstruction on clinical examination or development of
an aortic aneurysm via follow-up CxR/echocardiographic
examination. At follow-up, there were 103 (71.5%)
patients noted to have normal imaging with 41 parts
(28.5%) having abnormal follow-up imaging results. The
abnormal findings included: 16 patients (11%) with neoin-
timal hyperplasia, with 5 requiring repeat stent placement,
13 parts (9%) developed an aneurysm, 5 (3%) developed a
dissection/intimal tear, and 6 parts (4.2%) developed stent
fractures, 4 requiring repeat stent placement. The reinter-
vention rate was 9/41 (22%) for the group with abnormal
follow-up imaging. Comparisons were made between parts
with normal (group A) vs. those with abnormal (group B)
imaging at intermediate follow-up. In an attempt to iden-
tify the causalities, we performed subgroup analysis by
comparing normal follow-up image group vs. both aortic
wall injury and in-stent restenosis groups, respectively.
Group A (Normal Follow-Up)
One hundred and three patients (71.5%) had normal
imaging at a median follow-up interval of 12 months
(0.5–92 months) in the cohort study. In this group, the
mean age was 18.6 6 11 years and average weight
was 59.4 6 23.3 kg. Sixty-six patients (64%) were
diagnosed as native coarctation, with 73 (70%) parts
having their CoA located at the isthmus. Palmaz 8 and
10 series stents were used in majority of these proce-
dures and half of these stents were delivered on a BIB
balloon. Nine (8.7%) parts required two stents to cover
the entire coarctation segment. Pre- and poststent
implant minimal CoA diameters were 6.5 6 3.2 and
14.4 6 3.7 mm with mean percent change in CoA di-
ameter poststent implant of 180% 6 20%. Balloon:
CoA ratio was 3.0 6 2.0. In these procedures, pre-
and poststent coarctation systolic pressure gradients
were 35.6 6 19.5 and 2.8 6 4.4 mm Hg, respectively.
Group B (Abnormal Follow-Up)
There were 41 patients with abnormal findings at
follow-up imaging. Median follow-up period was 19.8
months (0.6 months, 84 months). The mean age was
16.0 6 11 years and average weight 49.1 6 22 kg.
Fifty four percent of the studies (n ¼ 22) were in
native coarctation, with 21 (52.6%) located at the isth-
mus, 8 at the distal transverse arch, and 4 at the ab-
dominal aorta. In this group, the Genesis, Palmaz 8,
and P10 series stents were used most frequently, being
delivered on BIB, Z med, or Cordis balloons in the
majority of cases.
Group A vs. Group B
Group B parts had significantly smaller prestent
CoA diameters (5.3 6 2.5 mm vs. 6.6 6 3.3 mm, P ¼
0.02) and poststent minimal CoA diameters (12.4 6
4.0 mm vs. 14.4 6 3.7 mm, P ¼ 0.008) in comparison
with group A parts. Percent (%) of increased CoA di-
ameter after stent placing in group A was 183% vs.
241% in group B (P < 0.001). The poststent residual
systolic pressure gradient was significantly higher in
group B (mean 5.2 6 7.3 mm Hg) vs. group A (mean
2.8 6 4.4 mm Hg) (P ¼ 0.02) parts. Patients in group
B were more likely to be smaller (P ¼ 0.03) and have
the coarctation in a location other than the usual isth-
mic region (P ¼ 0.008), such as distal transverse arch
or abdominal aorta. Age, discrete vs. long segment
coarctation, prestent gradient across the CoA, pre- and
postcoarct:decending aorta ratio, balloon:coarctation
ratio, nor stent type were not different between the
two groups. Please see Tables I, II and III.
Normal (Group A) vs. Aortic Wall Injury Group
Our definition of aortic wall injuries included dissec-
tion and aneurysm. A total 18 parts with median fol-
low-up interval 22.5 months (range 0.6 to 84 months),
showed vessel wall injury. Follow-up timeframe was
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not significantly different between the two groups.
Eight of 18 patients (44%) underwent prestent angio-
plasty prior to stent placement, which was significantly
higher than parts in group A 19/103 (18%) (P ¼ 0.04).
The percent increase in the prestent vs. poststent CoA
diameter (3.5 6 4.7% vs. 1.8 6 2.0%), and the bal-
loon: CoA ratio (4.7 6 4.9 vs. 3.0 6 2.0) was signifi-
cantly higher in the aortic wall injury group in com-
parison with the normal group (P ¼ 0.01). In review-
ing the data, we noted that exceeding a balloon:coarc
ratio >3.5 at the initial procedure significantly
increased occurrence of aortic wall injuries at follow-
up. Compared to patients with balloon:coarc <3.5, the
odds ratio of observing aortic wall injury at follow-up
imaging was 1.5 (confidence interval 0.5–4) in those





Injury (n ¼ 18)
Instent restenosis
(n ¼ 16)
Age (mean, SD) 18.6 (11.1) 20.4 (12.2) 9.8 (4.7)
Weight (mean, SD) 59.4 (23.3) 57.3 (19.7) 37.7 (21.3)
% Recurrent coarctation 37 (36%) 5 (27.9%) 11 (69%)
Time to F/U (Month) 12 (0.5–92) 22.5 (0.6–84) 14 (1.1–42.5)
Median (range)
Location
N (%) isthmus 73 (71%) 10 (56%) 6 (43%)
N (%) other 11 (29%) 3 (17%) 8 (57%)
Precoarctation diameter 6.6 (3.3) 5.4 (2.8) 5.2 (2.4)
Postdiameter 14.4 (3.7) 15.3 (3.1) 9.2 (2.5)
Increase in diameter 1.8 (2.0) 3.5 (4.7) 1.6 (1.8)
(X precoarctation diameter)
Balloon/coarctation ratio 3.0 (2.0) 4.7 (4.9) 3.1 (2.9)
Pregradient 35.6 (19.5) 41.3 (18.2) 34.8 (16.6)
Gradient post 2.8 (4.4) 4.9 (9.1) 5.8 (5.4)
N (%) with prestent angioplasty 19 (18%) 8 (44%) 6 (38%)












P8 series 26 11




CP series 16 5
Cp covered 5 3
Other 3 3





group (n ¼ 41) P value
Age (mean, SD) 18.6 (11.1) 16.0 (11.3)
Weight (mean, SD) 59.4 (23.3) 49.2 (22.7.0) 0.032
N (%) recurrent coarctation 37 (36%) 18 (45%)
Time to F/U (month) 12 (0.5–92) 19.75 (0.6–84)
Median (range)
Location
N (%) isthmus 73 (71%) 21 (53%) 0.0085
N (%) other 11 (29%) 12 (47%)
Precoarctation diameter 6.6 (3.3) 5.3 (2.5) 0.0283
Postdiameter 14.4 (3.7) 12.4 (4.0) 0.0082
Increase in Diameter 1.8 (2.0) 2.4 (3.5)
(X precoarctation diameter)
Balloon/coarctation ratio 3.0 (2.0) 3.7 (3.8)
Pregradient 35.6 (19.5) 42.7 (21.5)
Gradient post 2.8 (4.4) 5.2 (7.3) 0.0254
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Fig. 1. (A,B) A-P and lateral views of a discrete, native CoA
in the typical location in a 14-year-old girl. (C) S/p placement
of a Genesis XD stent across coarctation segment. No resid-
ual obstruction observed. Neither dissection nor aneurysm
formation noted. Balloon:coarct ratio of 2.2 was achieved.
(D) Approximately 2 years following initial stent placement,
development of a moderate sized aneurysm is noted. (E) S/p
placement of a CP covered stent with complete exclusion
of the coarctation aneurysm and no obstruction to flow
observed (courtesy M. Ebeid).
patients with balloon:coarc ratio 3.5. Age, weight,
location, and type of coarctation, pre- and postinter-
vention diameter of coarctation segment, encountering
a complication at time of initial intervention, pre- and
postintervention systolic pressure gradient were unre-
lated to encountering aortic wall abnormalities at inter-
mediate follow-up. Please see Table II.
Aneurysm
In our 144 patients that underwent IAI, 13 (9%)
developed an aneurysm. The time to follow-up after
initial stent placement was a median of 35.7 months
(8–84), which was significantly longer than group A
patients (12 months; P ¼ 0.009). The majority of
aneurysms were small, being managed conservatively
with observation. In four patients however, a signifi-
cant aneurysm developed which required further
intervention (Fig. 1A–E). Aneurysm formation oc-
curred most commonly at the site associated with the
narrowest segment of the coarctation, though in one
patient, the aneurysm started proximal to the previ-
ously placed stent. Development of aneurysms was not
Fig. 2. (A) Recurrent CoA following surgical repair noted. Surgical repair was performed 8
years prior. (B) Placement of Genesis XD stent across coarctation segment. Stent is
observed minimally crossing orgin of brachiocephalic vessel. No residual stenosis
observed. (C) Development of significant neointimal build-up within the stent 2 years after
initial stent deployment. (D) Placement of a second Genesis XD stent across previously
placed stent, no residual obstruction present.
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related to patients’ age, weight, initial diagnosis, recur-
rent vs. native coarctation, type of stent, encountering
an acute complication at time of initial intervention, or
balloon:coarct ratio.
Normal (Group A) vs. In-Stent Restenosis
We combined stent fracture (n ¼ 6) and neointimal
build up (n ¼ 16) to form the in-stent restenosis group,
though for further analysis, we excluded stent fracture,
discussing this group separately in the following section.
Please see Fig. 3. Comparisons between the two groups
noted that younger age (9.8 6 4.7 years vs. 18.6 6 11.1
years) (P ¼ 0.02) and lower weight at time of initial pro-
cedure (37.7 6 21 kg vs. 59.4 6 23.3 kg) (P ¼ 0.007)
was associated with the development of in-stent resteno-
sis at intermediate follow-up. In addition, smaller post-
stent diameter (9.2 6 2.5 mm vs. 14.4 6 3.7 mm) (P <
0.001) and poststent systolic gradient (5.2 6 5.4 mm Hg
vs. 2.8 6 4.4 mm Hg) (P ¼ 0.05) were also associated
with the development of in-stent restenosis at time of fol-
low-up. Location and type of coarctation, postinterven-
tion diameter of coarctation segment, encountering a
complication at time of initial intervention, presystolic
pressure gradient were unrelated to encountering instent
restenosis at intermediate follow-up.
One case of neoinitimal build-up occurred following
stent fracture, and two occurred with stent recoil (both
with the earlier version of the EV3 DS LD stent).
Please see Figure 2(A–D).
Stent Fracture
Six patients reported stent fractures. All were
encountered in native coarctation (please see Fig. 3).
Among them, CP stent was implanted in four and the
Genesis XD was placed in two procedures. There were
no fractures observed in the Palmaz ‘‘8/10’’ series or
the EV3 stents. Four parts required repeat stent place-
ment and one redilation due to reobstruction. No distal
fragments were observed, with the fractures either
being circumferential (Genesis series), or localized to
two to four neighboring cells (CP series).
The small number of stent fractures precluded any
meaningful analysis.
DISCUSSION
A number of studies have reported excellent clinical
results at intermediate follow-up in parts undergoing
IS placement in the treatment of native and recurrent
CoA [2–4,6,8,12,13,15,16]. However very few have
reported on IAI of the aorta following IS placement in
the treatment of CoA [3,14,17]. Though ultrasound
imaging was routinely obtained in all of these patients,
it may not reliable assess the severity of the gradient
across the stent. Furthermore, aortic wall abnormalities
may be missed due to artifact created by the stent.
Integrated aortic arch imaging is the best method to
assess aortic wall abnormalities and restenosis. To
date, this is the largest report of follow-up in patients
undergoing IAI following intravascular stent placement
for treatment of native and recurrent CoA. In our ex-
perience, we observed a 25.6% incidence of aortic
arch abnormalities following intravascular stent place-
ment. The most common abnormalities encountered
were the development of an aneurysm and intimal pro-
liferation within the stent.
Development of aortic wall aneurysms following
intravascular stent placement has been previously
described in numerous reports [2,9,10,16,17] with the
incidence of aneurysm formation ranging from 9 to
17%. The incidence in developing large aneurysms,
requiring further treatment, ranges from 0 to 9%
[2,3,9,17]. In Harrison’s report, out of 18 parts under-
going repeat cardiac catheterization (mean 1.3-years
follow-up time), three developed aneurysms. One was
in a native coarctation, with a very large (>2 cm) an-
eurysm that required surgical removal of the stent and
resection of the aneurysm [17]. The balloon:coarct ra-
tio was five in this patient. The other two aneurysms
were small and are currently being followed. In their
report, neither dissection nor significant neointimal
proliferation/restenosis was present. Ledesma et al. also
reported a large aneurysm formation at intermediate
Fig. 3. Circumferential fracture of a Genesis stent in a native
coarctation of the aorta, 2 years after intial implantation. This
was treated with a second Genesis stent placed within previ-
ously placed stent without further incident.
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follow-up in a native coarctation. In this patient, the
balloon to coarct ratio was 7.5 [9]. Suarez et al.
reported in 30 parts undergoing repeat cardiac catheter-
ization (mean 25-months follow-up) with no aneurysm
or dissections observed [2]. The cause and actual inci-
dence of aneurysm formation at intermediate follow-up
remain unknown. It is felt that overaggressive dilation
of the native coarctation segment (balloon:coarct ratio
>3.5) may contribute to aneurysm formation at inter-
mediate follow-up. Our experience supports this con-
tention, with a greater likelihood of encountering this
complication when one exceeds balloon:coarct ratio
>3.5. However, as depicted in Fig. 2, one can still
encounter aneurysm formation even when one takes a
conservative approach to stent dilation of the coarcta-
tion segment (balloon:coarct ratio 2.2). This is con-
cerning and underlies the importance of developing a
method to reliably assess aortic compliance prior to
stent placement. This also stresses the importance of
obtaining IAI of the aorta at reliable intervals follow-
ing coarctation stenting. It has been implicated that
native coarctation parts are more likely to encounter
aneurysm formation than recurrent coarctation parts.
We found no support for this, with an equal number of
native and recurrent coarctation patients encountering
aneurysm formation at follow-up. In our previous
report on acute complications, we noted that age was
associated with the development acute aortic of wall
injury following stent placement. However at interme-
diate follow-up, we noted no age preferences for the
development of aortic aneurysms.
Another factor, other than aortic wall compliance,
that influenced the development of aortic wall injury at
intermediate follow-up in our experience was perform-
ing prestent balloon angioplasty. In animal studies,
Ohkubo et al. reported that when compared with con-
ventional balloon angioplasty, primary stent implanta-
tion caused less vessel wall injury [18]. This conten-
tion was supported in a study by Magee et al., who
felt that primary stent placement, rather than balloon
angioplasty alone, supported the aortic wall, thus pre-
serving medial integrity and thereby preventing exten-
sion of tears through the media into the adventitial
layer [10]. Though the authors wanted to stress that
preballoon angioplasty is not the same as assessing
aortic wall compliance with balloon testing. Compliant
balloon testing was not performed routinely by any of
the authors during initial stent deployment and there-
fore was not evaluated in this study. Preballoon angio-
plasty, as we define it, related to an aggressive attempt
to eliminate coarctation stenosis prior to initial stent
deployment.
An equally common occurrence noted at intermedi-
ate follow-up was the development of neointimal pro-
liferation within the stent. In our experience, the loca-
tion of CoA and smaller poststent CoA diameter were
the two most important prognostic factors determining
the development of neointimal buildup within the stent.
Conversely, Duke et al. noted that overdilating the
stent at time of implantation contributed to neointimal
build-up [19]. Furthermore, we noted that younger age,
lower weight, and recurrent coarctation all had a
higher incidence of neointimal build-up at intermediate
follow-up. Similar results were obtained by Suarez de
Lezo et al., where their incidence of neointimal build-
up within the stent was 27% at a mean 23-months fol-
low-up, [2]. This likely is directly related to vessel
injury. Hunter et al. noted in an animal model of arte-
rial injury, that vascular endothelial growth factor
(VEGF) inhibited the formation of neointima following
arterial injury by accelerated endothelial repair. In that
same study, they noted that sequestration of exogenous
and/or endogenous VEGF delayed reendothelialization,
significantly increasing neointimal proliferation [20]. It
may be that drug eluding stents will play a large role
in preventing neointimal build-up within the stent,
though this remains speculative at this time.
Limitations
This study is a retrospective review, with all the at-
tendant limitations associated in performing such a
study. Follow-up IAI studies were done as protocol in
just three institutions. The majority of imaging studies
were performed due to concerns of either reobstruction
or the development of an aortic aneurysm. Therefore,
over estimation of poststent aortic arch abnormalities
is likely to have occurred in our cohort group.
CONCLUSION
Exceeding balloon:coarct ratios >3.5 and prestent
angioplasty should be avoided in patients undergoing
intravascular stent placement for CoA. The true inci-
dence of abnormal findings on aortic arch imaging fol-
lowing IS treatment of CoA remains unknown, since
only 27% of the parts underwent IAI following IS
treatment of their aortic coarcation. We feel that rou-
tine IAI following intravascular stent treatment of aor-
tic coarctation is imperative in this group of parts.
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